Femara half-life
Letrozole is a prescription aromatase inhibitor with a long terminal half-life of about 2 days, so it clears the blood slowly and is taken once daily. Because each dose leaves the body slowly, the drug accumulates with repeated dosing and reaches a steady level after roughly 2 to 6 weeks. It is broken down into an inactive metabolite cleared by the kidneys, so no long-lived active byproduct extends its duration.
What a half-life actually means
A half-life is the time it takes for half of what is in your blood to be gone. It does not mean the compound is finished at that point. Half goes, then half of what is left goes, and so on.
That is why the last traces take so much longer to disappear than the first. Most references treat something as effectively cleared after about five half-lives, which for Femara is roughly 10 days.
How Femara clears
| Half-lives | Time since dose | Roughly left |
|---|---|---|
| 1 | 2 days | 50% |
| 2 | 4 days | 25% |
| 3 | 6 days | 12.5% |
| 4 | 8 days | 6.25% |
| 5 | 10 days | 3.125% |
These are round numbers from a single half-life figure. Real clearance shifts with dose, body composition, liver and kidney function, and what else you are taking. Treat it as a shape, not a schedule.
Why the timing matters
A short half-life means levels swing between doses, so timing and frequency do most of the work. A long half-life means levels build for days or weeks before they settle, so a change you make today might not show up for a while, and stopping does not clear things straight away.
Femara sits at about 2 days, so it behaves like the medium end of that range.
See your own levels, not a table
NextDose models your actual blood level from the doses you log, then calibrates the curve to your bloodwork. Built on 30,000+ research papers, clinical trials and FDA records.
Get NextDose.AIResearch mentioning Femara
Indexed records from PubMed and ClinicalTrials.gov that reference Femara. These are here so you can read the primary material yourself. They are not the source of the half-life figure above.